Recent blog posts
FZD6 Biologics Sequence Review Report 2026: Frizzled-6 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
FZD6 Biologics Sequence Review Report 2026: Frizzled-6 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FZD6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
C4B Biologics Sequence Review Report 2026: Complement C4-B Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
C4B Biologics Sequence Review Report 2026: Complement C4-B Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of C4B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
C4A Biologics Sequence Review Report 2026: Complement C4-A Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
C4A Biologics Sequence Review Report 2026: Complement C4-A Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of C4A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
C5 Biologics Sequence Review Report 2026: Complement C5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
C5 Biologics Sequence Review Report 2026: Complement C5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of C5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TRPM2 Biologics Sequence Review Report 2026: Transient receptor potential cation channel subfamily M member 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TRPM2 Biologics Sequence Review Report 2026: Transient receptor potential cation channel subfamily M member 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TRPM2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
C3 Biologics Sequence Review Report 2026: Complement C3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
C3 Biologics Sequence Review Report 2026: Complement C3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of C3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PLXNB1 Biologics Sequence Review Report 2026: Plexin-B1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PLXNB1 Biologics Sequence Review Report 2026: Plexin-B1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PLXNB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NCAM1 Biologics Sequence Review Report 2026: Neural cell adhesion molecule 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NCAM1 Biologics Sequence Review Report 2026: Neural cell adhesion molecule 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NCAM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MRC1 Biologics Sequence Review Report 2026: Macrophage mannose receptor 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MRC1 Biologics Sequence Review Report 2026: Macrophage mannose receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MRC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MS4A1 Biologics Sequence Review Report 2026: B-lymphocyte antigen CD20 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MS4A1 Biologics Sequence Review Report 2026: B-lymphocyte antigen CD20 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MS4A1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LY6G6C Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6c Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LY6G6C Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6c Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LY6G6C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRP6 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 6 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LRP6 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 6 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →